Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Long Term Outcomes ◽

Randomized Controlled ◽

Re: Long-Term Outcomes of a Randomized Controlled Trial Comparing Thermochemotherapy With Mitomycin-C Alone as Adjuvant Treatment for Non-Muscle-Invasive Bladder Cancer (NMIBC)

The Journal of Urology ◽

10.1016/j.juro.2011.08.052 ◽

2011 ◽

Vol 186 (5) ◽

pp. 1808-1809

Author(s):

David P. Wood

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Long Term Outcomes ◽

Randomized Controlled ◽

LONG-TERM OUTCOMES OF A RANDOMIZED CONTROLLED TRIAL COMPARING THERMOCHEMOTHERAPY WITH MITOMYCIN-C ALONE AS ADJUVANT TREATMENT FOR NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC)

BJU International ◽

10.1111/j.1464-410x.2011.10310_1.x ◽

2011 ◽

Vol 107 (10) ◽

pp. 1685-1685 ◽

Author(s):

Endre Z. Neulander ◽

Jacob Kaneti

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Long Term Outcomes ◽

Randomized Controlled ◽

944 Results of the first randomized controlled trial comparing intravesical radiofrequency induced chemohyperthermia with mitomycin-C versus BCG for adjuvant treatment of patients with intermediate- and high-risk non-muscle invasive bladder cancer

10.1016/s1569-9056(15)60932-0 ◽

2015 ◽

Vol 14 (2) ◽

pp. e944-e944a ◽

Cited By ~ 6

Author(s):

T.J.H. Arends ◽

O. Nativ ◽

M. Maffezzini ◽

O. De Cobelli ◽

A.G. Van Der Heijden ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Randomized Controlled ◽

1669 INTRAVESICAL ADJUVANT ELECTROMOTIVE MITOMYCIN-C IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER A RANDOMIZED CONTROLLED TRIAL

The Journal of Urology ◽

10.1016/j.juro.2012.02.1527 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Savino Mauro Di Stasi ◽

Cristian Verri ◽

Emanuele Liberati ◽

Francesco Micali ◽

Francesco Masedu ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Intermediate Risk ◽

Randomized Controlled ◽

Intravesical adjuvant electromotive mitomycin-C in patients with primary intermediate-risk urothelial non-muscle invasive bladder cancer: A randomized controlled trial

10.1016/s1569-9056(19)33633-4 ◽

2019 ◽

Vol 18 (9) ◽

pp. e3248

Author(s):

S. Di Stasi ◽

V. Ambrosi Grappelli ◽

V. Pagliarulo ◽

C. Fede Spicchiale ◽

A. Giannantoni ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Intermediate Risk ◽

Randomized Controlled ◽

HIVEC HR: Chemohyperthermia with mitomycin C vs BCG for high-risk non-muscle invasive bladder cancer. Preliminary results from a randomized controlled trial

10.1016/s1569-9056(19)30563-9 ◽

2019 ◽

Vol 18 (1) ◽

pp. e768-e770 ◽

Author(s):

D.A. González Padilla ◽

A. González Díaz ◽

N. Miranda-Utrera ◽

F. De La Rosa Kehrmann ◽

F. Villacampa-Aubá ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Preliminary Results ◽

Randomized Controlled ◽

1045 Intravesical adjuvant electromotive drug administration (EMDA®) of mitomycin-C in patients with intermediate-risk non-muscle invasive bladder cancer: A randomized controlled trial

10.1016/s1569-9056(12)61041-0 ◽

2012 ◽

Vol 11 (1) ◽

pp. e1045-e1045a ◽

Author(s):

S.M. Di Stasi ◽

C. Verri ◽

E. Liberati ◽

F. Micali ◽

F. Masedu ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Drug Administration ◽

Controlled Trial ◽

Intermediate Risk ◽

Randomized Controlled ◽

Muscle Invasive ◽

Electromotive Drug Administration

The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non–muscle-invasive bladder cancer: A preliminary results of randomized controlled trial

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2018.10.019 ◽

2019 ◽

Vol 37 (3) ◽

pp. 179.e9-179.e18 ◽

Cited By ~ 3

Author(s):

Amr A. Elsawy ◽

Ahmed M. El-Assmy ◽

Mahmoud A. Bazeed ◽

Bedeir Ali-El-Dein

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Preliminary Results ◽

Randomized Controlled ◽

Re: Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C versus bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer

The Journal of Urology ◽

10.1016/j.juro.2018.06.043 ◽

2018 ◽

Vol 200 (4) ◽

pp. 696-697

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Randomised Controlled Trial ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Bacillus Calmette Guerin ◽

Muscle Invasive ◽

Randomised Controlled

Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: A single center randomized controlled trial

International Journal of Urology ◽

10.1111/j.1442-2042.2012.03174.x ◽

2012 ◽

Vol 20 (4) ◽

pp. 399-403 ◽

Cited By ~ 30

Author(s):

Alessandro Del Rosso ◽

Gianna Pace ◽

Stefano Masciovecchio ◽

Pietro Saldutto ◽

Giuseppe Paradiso Galatioto ◽

...

Keyword(s):

Bladder Cancer ◽

Transurethral Resection ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Single Center ◽

Randomized Controlled ◽